Young Investigator Awards

Twelve Young Investigator Awards, worth €1500 each, are awarded to researchers who submit abstracts (basic or clinical) to the annual European Congress of Endocrinology.


Applicants must indicate on the abstract form whether they wish to be considered for an ESE Young Investigator Award.


Successful applicants must be within 10 years post-PhD or MD and a member of ESE at the time of the meeting. 


The awards are based on the achieved abstract scores, as determined by the ECE abstract review committee; the final decision is made by the ECE Programme Organising Committee.

ECE 2017 Winners

Ms Taís Silveira Assmann: microRNA expression profile in plasma from patients with type 1 diabetes: a case-control study and bioinformatics analysis 

Dr Elizabeth Baranowski: Steroid Metabolomics for Accurate and Rapid Diagnosis of Inborn Steroidogenic Disorders 

Dr Leticia Brondani: Urinary peptidomics for the detection of diabetic kidney disease

Assistant Professor Sabrina Chiloiro: Effects of pegvisomant and somatostatin receptor ligands on risk of vertebral fractures in patients with acromegaly

Dr Carla Di Dato: Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the Serena Study' a randomized, double-blind, placebo-controlled trial 

Miss Milena Doroszko: Luteinizing hormone receptor mediated GATA4 induction promotes adrenocortical tumorigenesis in gonadectomized mice 

Mr Andreas Ebbehøj: The Epidemiology of Pheochromocytoma: Increasing Incidence and Changing Clinical Presentation. A population-based retrospective study 1977-2015

Ms Camilla Maria Falch: RNA sequencing and RT-qPCR identify different gene expression profiles in fast- vs. slow-growing non-functioning pituitary adenomas 

Dr Nazarii Kobyliak: Probiotics and nutraceuticals as a new frontier in obesity prevention and management 

Mr Konrad Patyra: Inducible thyrocyte-specific Gs alpha-deficient mice as a novel model for hypothyroidism

Associate Professor Anna Shalimova: Effectiveness of complex therapy in patients with comorbidity of type 2 diabetes and essential hypertension depending on genetic polymorphism PPARy2

Dr Sandrine Urwyler: Interleukin-1 antagonism decreases cortisol levels in obese individuals 

Subscribe to our email alerts